Flow Cytometry and Immune Monitoring Shared Resource Facility
FCIM SRF Overview
The overall mission of the Flow Cytometry and Immune Monitoring Shared Resource Facility (FCIM SRF) is to provide technical and scientific support for MCC investigators whose research programs require flow cytometric cell analysis and/or sorting or other immune-based cell assays. FCIM provides access to a team of expert immunologists and state of art instruments to aid pre-clinical, translational, and clinical research activities at the Markey Cancer Center. The FCIM team comprises experts in flow cytometry, tumor immunology, immunotherapy, vaccine biology, inflammation, autoimmune diseases, immune biomarker discovery, drug development and testing. We provide both fee-based services and scientific collaboration for research requiring immune system expertise for both human or animal studies.
Visit the full Flow Cytometry and Immune Monitoring Shared Resource Facility site for more information.
Full FCIM Website
- Provide cost-effective state-of-the-art flow cytometry and cell sorting services for basic, preclinical and clinical researchers.
- Provide cost-effective state-of-the-art immune monitoring services for basic, pre-clinical and clinical researchers.
- Provide educational training and mentoring to MCC members and/or laboratory staff in proper use of self-service instrumentation and appropriate experimental design and data analysis.
Requests for services can be made by contacting either the Flow Cytometry & Cell Sorting Lab or the Immune Monitoring Lab.
Reservations for services on particular FCIM instrumentation can be made through the PPMS website.
Where is the FCIM located?
The core is located in two adjoining labs, Lab Suite 076 (Flow Cytometry) and Lab Suite 076A (Immune Monitoring) in the Healthy Kentucky Research Building (HKRB).
What are the FCIM hours?
Staff are at the facility Monday through Friday, 9:30 am - 5:00 pm.
Who should I contact regarding scheduling and general questions about services and billing for Flow Cytometry?
Who should I contact concerning experimental design, assay development, and biosafety issues?
Acknowledge the FCIM SRF
Investigators are required to acknowledge the Markey Cancer Center Flow Cytometry and Immune Monitoring Shared Resource Facility (FCIM SRF) in any publications that result from the use of biospecimens or information received through the MCC FCIM SRF. Please use the following statement to acknowledge the FCIM SRF.
“This research was supported by the Flow Cytometry and Immune Monitoring Shared Resource Facility of the University of Kentucky Markey Cancer Center (P30CA177558).”